Ms. Chahra Louafi serves as Senior Investment Director at Bpifrance. She also serves as a member of Board of Directors at Gecko Biomedical, Pixium, ENYO Pharma, Sensorion, BrainEver and DBV Technologies. Prior to joining Bpifrance, Ms. Louafi was at CDC Entreprises, where she joined in 2001 and was in charge of initiating and implementing projects, as well as creating in a private business incubator specialized in biotechnology, Mendel Partner. Within CDC Entreprises, Chahra Louafi (Investment Director) was in charge, inter alia, of funds of funds investments focused on seed funds and biotech funds, and tech transfer transactions. Since October 2009, she joined the management team of InnoBio fund, a fund dedicated to biotech companies, managed by CDC Entreprises and invested by the pharmaceutical industry. Chahra Louafi is member of the supervisory board of Cap Décisif Management. Chahra Louafi graduated from Paris Dauphine University (Masters of Technology and Innovation Management), Paris X Nanterre University (Masters of Corporate Finance) and Institut National Agronomique de Paris - Grignon (Masters of Microbiology and Enzymatic Engineering). She also serves as a Board Member at Therachon. She also served as Board Member at Inserm Transfert Initiative.